Storz Ulrich, Faltus Timo
Michalski ⋅ Hüttermann & Partner Patent Attorneys, Düsseldorf, Germany.
Martin Luther University, Halle-Wittenberg, Germany, Faculty of Law, Economics and Business.
Regen Med. 2017 Jan;12(1):37-51. doi: 10.2217/rme-2016-0099. Epub 2016 Dec 15.
Since 2006, some of the highest ranking European Courts have issued decisions related to the patent eligibility of human embryonic stem cells. The question of patent eligibility of human embryonic stem cells remains, however, still erratic, at least in some aspects. This article will give a short comprehensive overview of the case history, and discuss questions still unsolved.
自2006年以来，一些欧洲最高法院已就人类胚胎干细胞的专利适格性问题作出裁决。然而，人类胚胎干细胞的专利适格性问题至少在某些方面仍然不稳定。本文将简要全面地概述相关的案件历史，并讨论尚未解决的问题。
